Literature DB >> 2700068

Strategies for calibrating a subcutaneous glucose sensor.

G Velho1, P Froguel, D R Thevenot, G Reach.   

Abstract

The calibration of the glucose sensor is a critical issue for the subcutaneous implantation of such devices, since it allows from the sensor output the estimation of the prevailing subcutaneous glucose concentration. This study has compared estimations of subcutaneous glucose concentration in rats, calculated from the sensor's signal by using calibration parameters (sensitivity coefficient and background current) determined either under in vitro or in vivo conditions. The in vitro calibration was performed in phosphate buffer at 37 degrees C. The in vivo parameters were calculated by comparing changes in the sensor output current to concomitant changes in blood glucose concentration, induced by intravenous insulin injection and glucose infusion. The apparent subcutaneous glucose concentration, calculated with in vitro parameters, remained much lower than the concomitant blood glucose levels throughout the experiments. By contrast, when it was calculated with the calibration parameters determined in vivo, either in the hypoglycemia or hyperglycemia range, the apparent subcutaneous glucose concentration well reflected blood glucose levels with a five min time lag. We conclude that it is the two-point in vivo calibration procedure which allows the calculation of an apparent subcutaneous glucose concentration best reflecting blood glucose levels.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2700068

Source DB:  PubMed          Journal:  Biomed Biochim Acta        ISSN: 0232-766X


  8 in total

1.  Use of subcutaneous interstitial fluid glucose to estimate blood glucose: revisiting delay and sensor offset.

Authors:  Kerstin Rebrin; Norman F Sheppard; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

Review 2.  In vitro, in vivo and post explantation testing of glucose-detecting biosensors: current methods and recommendations.

Authors:  Heidi E Koschwanez; William M Reichert
Journal:  Biomaterials       Date:  2007-04-19       Impact factor: 12.479

3.  Inflammation and glucose sensors: use of dexamethasone to extend glucose sensor function and life span in vivo.

Authors:  Ulrike Klueh; Manjot Kaur; David C Montrose; Donald L Kreutzer
Journal:  J Diabetes Sci Technol       Date:  2007-07

4.  A glucose monitoring system for on line estimation in man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue and a wearable control unit.

Authors:  V Poitout; D Moatti-Sirat; G Reach; Y Zhang; G S Wilson; F Lemonnier; J C Klein
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

5.  Putative delays in interstitial fluid (ISF) glucose kinetics can be attributed to the glucose sensing systems used to measure them rather than the delay in ISF glucose itself.

Authors:  Gayane Voskanyan; D Barry Keenan; John J Mastrototaro; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2007-09

6.  Towards continuous glucose monitoring: in vivo evaluation of a miniaturized glucose sensor implanted for several days in rat subcutaneous tissue.

Authors:  D Moatti-Sirat; F Capron; V Poitout; G Reach; D S Bindra; Y Zhang; G S Wilson; D R Thévenot
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

7.  Reduction of acetaminophen interference in glucose sensors by a composite Nafion membrane: demonstration in rats and man.

Authors:  D Moatti-Sirat; V Poitout; V Thomé; M N Gangnerau; Y Zhang; Y Hu; G S Wilson; F Lemonnier; J C Klein; G Reach
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

8.  Responses and calibration of amperometric glucose sensors implanted in the subcutaneous tissue of man.

Authors:  J C Pickup; D J Claremont; G W Shaw
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.